CompletedNCT00276874
Aripiprazole or placebo to prevent cocaine relapse
About this title
Read the official source — NCT00276874Medication studyAges 18–50United StatesAddiction
Understand this study
Who was this study for?
Listed age limits: 18 years to 50 years.
- Listed locations
- LexingtonSee all locations and recruitment
- Study phase
- Phase 1Usually an early study focused on safety, tolerability, dosage, and side effects.
Study information
Study start dateJanuary 2006
- Recruitment status
- Completed
- Enrollment listed in the registry
- 41
- Sponsor
- Craig Rush
- Sponsor type
- Unknown or unclear
- Study type
- Drug
- Intervention type
- Medication / drug
- Study phase
- Phase 1Usually an early study focused on safety, tolerability, dosage, and side effects.
- Locations
- United States
- Age range
- From 18 Years to 50 Years
- Official registry ID
- NCT00276874
- Official title
Show the full official title
Preventing Cocaine Relapse: Developing Pharmacotherapies
Looking for a study you can join?
Explore recruiting studiesRecruitment & locations
CompletedThis badge reflects the study status reported by the registry. Check the registry for the latest information.
Lexington
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is Craig Rush.
Did this study involve medication?
Yes. The study involved medication, including Aripiprazole and Placebos.
Who was this study for?
Listed age limits: 18 years to 50 years.
